Soulful Science Podcast
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are some of the most talked-about drugs in wellness and medicine right now. But what do they actually do? What should you know before using them? In this episode, we break down: * 🔬 The science behind how GLP-1 receptor agonists work * ⚖️ Who they’re for and what kind of results are realistic * 💊 Side effects & precautions every user should know * 🏋️♀️ Fitness and nutrition strategies to protect muscle and support metabolism * 💬 Myths vs. facts about safety, weight regain, and long-term use 🎧 Whether you’re curious about starting these medications, coaching clients who use them, or just want to understand the hype, this episode arms you with evidence-based, practical insight. 📎 Download your free listener handout: GLP1_Listener_Handout_SoulfulScience.pdf [https://acrobat.adobe.com/id/urn:aaid:sc:US:94255365-d071-4dea-8d0f-03ccd66376c0 ] References for Show Notes: * FDA Wegovy Prescribing Information (Semaglutide) [https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf] * FDA Zepbound Approval & Tirzepatide Info [https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management] * NEJM SELECT Cardiovascular Outcome Trial for Semaglutide [https://www.nejm.org/doi/full/10.1056/NEJMoa2303303] * StatPearls: GLP-1 Receptor Agonists Review [https://www.ncbi.nlm.nih.gov/books/NBK551568/] * FDA Consumer Warning on Unapproved Semaglutide Products [https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-patients-and-health-care-providers-about-unapproved-versions-glp-1-drugs-used-weight-loss]
18 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Soulful Science Podcast!